Aravind Ganesh @draravindganesh

Associate Professor, Stroke & Cognitive Neurologist @DCNSNeuro. CEO @letsgetproof. MD @UCalgaryMed, DPhil (Clin Neuro) @UniofOxford, FRCPC(Neuro) @Royal_College Joined January 2015

Tweets

3K
Followers

1K
Following

568
Likes

8K

Alberta Neuroscience @ABneurosci

a month ago

Dr. Philip Barber shares a powerful message of gratitude and purpose. His work focuses on identifying the earliest signs of dementia to improve chances of preventing or treating it more effectively. Find out more: albertaneuro.ca/hope-for-tomor… @Helpfordementia @UCalgary @UAlberta

0 2 2 144 0

Download Image

Alberta Neuroscience @ABneurosci

3 weeks ago

2024 Hope for Tomorrow Research Competition awardee, Dr. Eric Smith shares how this support is enabling new, innovative work to improve the diagnostic process for patients with cognitive disorders. Find out more: albertaneuro.ca/hope-for-tomor… @Helpfordementia @UCalgary @UAlberta

0 3 3 155 0

Download Image

Heart & Stroke @HeartandStroke

4 weeks ago

"It's an exciting time in healthcare research." Dr. Philip Barber is clear about the goal of his research. It’s right there in the title of his study: PREVENT VCI. Read how he is using machine learning to take aim at vascular cognitive impairment: bit.ly/4o8l1HX.

1 2 5 719 0

Download Image

nishita singh @nishita_singh3

a month ago

… hopefully soon! Until then let’s enrol in the @Dose_actglobal trial! @bijoymenon

Stephan A Mayer @stephanamayer

a month ago

… hopefully soon! Until then let’s enrol in the @Dose_actglobal trial! @bijoymenon

5 36 88 7K 42

0 1 1 230 0

Stroke AHA/ASA @StrokeAHA_ASA

a month ago

Check out the #Stroke Special Report by @mayank_G0 & @draravindganesh et al. ⬇️ ahajournals.org/doi/full/10.11… @AlmekhlafiMa @Katha_MD @nishita_singh3 @UPensato @mirandamwan @bijoymenon @SCouttsMD @johanna_ospel @JAKrommMD @PoppeAY @lucianacatanese @mihill68 @DCNSNeuro @UCalgaryMed

0 5 9 1K 2

Canadian Journal of Neurological Sciences @JournalCJNS

2 months ago

#CJNS #PromotedArticle #FirstView -Automatic Matching Algorithms to Identify Eligible Participants for Stroke Trials: A Proof-of-Concept Study- doi.org/10.1017/cjn.20… #ClincalTrials #Neurology @SocCdnNSx #CSCN #CACN @TheCSNR @CSC_Stroke #CNSF @CNSFNeuroLinks @CambUP_Psych

0 3 2 290 1

DOSEtrial @Dose_actglobal

2 months ago

🩺 Why DOSE? The #DOSETrial is evaluating both low-dose (0.18mg/kg) and standard-dose (0.25 mg/kg) tenecteplase to find the safest, most effective approach in patients within <48h DOAC intake. Critical gap. Adaptive answers. #Stroke #Thrombolysis #ACTGlobal

1 2 2 202 0

DOSEtrial @Dose_actglobal

2 months ago

🚨 Excited to launch the official X account for the DOSE Trial! DOAC associated Stoke Thrombolysis Optimization (DOSE) Trial is now recruiting across international sites. Follow us for real-time updates, milestones, and insights. #StrokeResearch #Thrombolysis #ACTGLOBAL

0 3 6 690 0

Download Image

Aravind Ganesh @draravindganesh

2 months ago

🚨 In this worldwide Practice Current survey of neurologists on mgmt of MCI, there was cautious optimism re: anti-amyloid therapies, with concerns about side effects but a general interest to prescribe: neurology.org/doi/10.1212/CP… @GrahamAMcLeod, Aaron Switzer, Eric Smith @DCNSNeuro

0 6 9 581 2

Download Image

Umberto Pensato MD 🇮🇹 🇨🇦 @UPensato

2 months ago

The Canadian Outcome Scale for Minor Stroke (COSMOS): a much-needed, novel 7-point scale to assess more Individualized outcomes in patients with minor stroke (mRS is not sufficient). @StrokeAHA_ASA Kudos to @mayank_G0 @draravindganesh Salome and team. ahajournals.org/doi/10.1161/ST…

1 29 51 5K 12

Download Image

Mayank Goyal @mayank_G0

2 months ago

0 9 35 2K 2

Download Image

Heart & Stroke @HeartandStroke

2 months ago

“We're putting that lens on this lifespan trajectory of how risk and resilience manifests in congenital heart disease (CHD) over the life course.” The effects of CHD on the brain are not well understood. Dr. Thalia Field wants to change that. #BeatStroke #StrokeMonth

0 2 6 500 0

NEJM @NEJM

2 months ago

In adults with myasthenia gravis, treatment with intravenous inebilizumab, a CD19-specific monoclonal antibody, significantly improved function and reduced disease severity at 26 weeks. Full MINT phase 3 trial results and Research Summary: nej.md/4j8TiUo

3 38 138 18K 24

Download Image

Heart & Stroke @HeartandStroke

3 months ago

Dr. @nishita_singh3 aims to revolutionize stroke causes and treatment. From her experience working in rural India to the day she came to Canada, Dr. Singh has been advocating and working towards equitable, life-saving stroke treatments in Canada and globally. #StrokeMonth

0 3 10 2K 0

Let's Get Proof @letsgetproof

3 months ago

🚨In our latest blog post, Jaanya Lal discusses what happens in our brains when our immune system turns against us, “From Defence to Danger”: letsgetproof.com/blog/defence-t…

0 3 3 175 0

Download Image

DCNS Calgary @DCNSNeuro

3 months ago

Thank you to Muse Laroyia and Dr. Bhavini Gohel for their advocacy around climate change and neurological health. "Wildfire smoke can harm your brain, not just your lungs" theconversation.com/wildfire-smoke… via @ConversationCA @UCalgaryMed

0 2 3 252 0

Aravind Ganesh @draravindganesh

3 months ago

🚨🧠Reflections and comments on our study of brain frailty and stroke severity in @AANmember @GreenJournal @joachimfladt @DCNSNeuro neurology.org/doi/10.1212/WN… Thank you @NeurologyToday!

Neurology Today @NeurologyToday

3 months ago

🚨🧠Reflections and comments on our study of brain frailty and stroke severity in @AANmember @GreenJournal @joachimfladt @DCNSNeuro neurology.org/doi/10.1212/WN… Thank you @NeurologyToday!

0 1 7 2K 1

Download Image

1 6 15 1K 1

Let's Get Proof @letsgetproof

3 months ago

🚨 Multiple Sclerosis is a neuro disease for which med research has made major strides over the past decades. Check out our latest blog post from Arshdeep Bhullar on Clinical Manifestations, Diagnosis & Clinical Course of MS! (therapeutics post to follow) letsgetproof.com/blog/multiple-…